High-dose influenza vaccines were associated with lower rates of hospitalization among patients on dialysis, compared with standard doses of the vaccine.
Travelers who cross the US-Mexico border 8 or more times per month have a lower rate of influenza vaccination than those who cross less frequently.
Point-of-care testing for influenza has a role persons with influenza-like illnesses, particularly in emergency departments and during influenza epidemics, but tests are not a substitute for clinical assessment.
Prior-season influenza vaccination history was not associated with reduced vaccine effectiveness in children.
Statin use did not modify the effect of vaccination on influenza in adults ≥45 years.
The use of high-dose influenza vaccines was low among patients with end-stage renal disease, who may not benefit from standard influenza vaccines.
Seasonal influenza activity was also found to be low in the Southern Hemisphere.
Significant reduction seen in hospitalization with receipt of high-dose versus standard-dose vaccine.
The vaccines are indicated for active immunization against influenza disease caused by virus subtypes A and type B present in the vaccine.
"This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years," said FDA Commissioner Scott Gottlieb, MD.
Research results indicated vaccination rates declined as clinic day progressed and that active choice intervention was linked with increased vaccinations.
Patients with acute respiratory distress syndrome and confirmed influenza diagnosis treated ≤6 hours with oseltamivir had reduced length of hospital stay and a lower rate of mortality.
Population density and structure may impact the length of the influenza season regardless of climatic conditions.
Double-dose influenza vaccine is safe and may increase antibody response in solid-organ transplant recipients
Elderly patients who have been inoculated with the influenza vaccine and who also use a statin are at a greater risk for medically attended acute respiratory illness.
Repeated exposure to the influenza virus affects antibody quantity and quality, and strains selected for seasonal vaccines may not provide coverage sufficient for individuals frequently infected and/or vaccinated.
Just over three-quarters of health care personnel received a flu vaccine last season.
NasoVAX, an adenovirus-based intranasal flu vaccine, shows tolerability, safety, and higher cellular immune response compared to an injectable vaccine.
When compared to placebo, baloxavir marboxil was associated with reduced risk of influenza complications and faster recovery.
2017 to 2018 flu strains affect the very young and elderly especially signifantly; poor vaccine/strain match-up
Mandatory genetic testing may also constitute an undue threat to employee autonomy and privacy.
An active choice intervention is associated with an increase in influenza vaccination rates.
A single dose of baloxavir marboxil was superior to placebo in controlling influenza symptoms in patients with uncomplicated disease.
Influenza proved to be an independent risk factor for invasive pulmonary aspergillosis.
All children and adolescents are advised to undergo annual influenza immunization, ideally with an inactivated influenza vaccine.
The mysterious illness that kept a plane away from the terminal after some passengers reported feeling sick has been confirmed as the flu.
According to the Centers for Disease Control and Prevention (CDC), the 2017-2018 flu season was one of the most severe - excluding pandemics - on record.
KLRD1-expressing natural killer cells may be a biomarker for influenza susceptibility.
Specimens of the rapidly evolving virus are needed to develop vaccines and treatments.
Obesity may play an important role in influenza transmission, highlighting the importance of working toward controlling and preventing the obesity epidemic.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Dundee Severity Classification Improves Management of Patients With Cellulitis
- Three New Ebola Vaccines Demonstrate Persistent Immune Response
- Isavuconazole Not Noninferior to Caspofungin for Invasive Candida Infections
- Pregnant Women Commonly Refuse Vaccines
- Tap Water in Neti Pot Linked to Death From Brain-Eating Amoeba
- Prenatal Malaria Exposure Modulates Innate Immune Responses at Birth
- Best Approach to Reduce Surgical Site Infections Before Colorectal Surgery
- A Single Triple-Drug Treatment for Lymphatic Filariasis
- Cyclosporiasis Cases Markedly Higher in 2018 Than Previous 2 Years
- Mail-Based HPV Testing May Increase Access